A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

Mayo Clinic, Phoenix, Arizona, United States

The Oncology Institute of Hope and Innovation, Cerritos, California, United States

University of California Irvine, Irvine, California, United States

Stanford University, Palo Alto, California, United States

Sharp Memorial Hospital, San Diego, California, United States

Georgetown University, Washington D.C., District of Columbia, United States

Memorial Cancer Institute, Hollywood, Florida, United States

Cancer Specialists of North Florida, Jacksonville, Florida, United States

Mayo Clinic, Jacksonville, Florida, United States

Emory Winship Cancer Institute, Atlanta, Georgia, United States

Northwest Oncology & Hematology, Rolling Meadows, Illinois, United States

Dana Farber Cancer Center, Boston, Massachusetts, United States

Karmanos Cancer Center, Detroit, Michigan, United States

Mayo Clinic, Rochester, Minnesota, United States

Billings Clinic Cancer Center, Billings, Montana, United States

St. James Healthcare, Butte, Montana, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Averra Medical Group, Sioux Falls, South Dakota, United States

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Huntsman Cancer Institute, Salt Lake City, Utah, United States

Utah Cancer Specialists, Salt Lake City, Utah, United States

Hematology-Oncology Specialist of Fredericksburg, Fredericksburg, Virginia, United States

Virginia Mason Hospital & Seattle Medical Center, Seattle, Washington, United States

Hematology Oncology Associates, Spokane, Washington, United States

Northwest Medical Specialties, Tacoma, Washington, United States

Salzburger Universitatsklinikum, Salzburg, Austria

UZ Leuven, Leuven, Belgium

Princess MargaretCancer Centre, Toronto, Ontario, Canada

Rigshospitalet, Copenhagen, Denmark

Centre Leon Berard, Lyon, France

Hospital Louis Pradel, FR, Lyon, France

Institut Gustave Roussy, Paris, France

Hopital Cochin, Paris, France

Hopital Curie, Paris, France

Asklepios Klinik Altona, Hamburg, Germany

Asklepios Kliniken Hamburg GmbH, Hamburg, Germany

Deutsches Krebsforschungszentrum, Heidelberg, Germany

Shaare Zedek Medical Center, Jerusalem, Israel

Sheba Medical Center, Tel Aviv, Israel

Niguarda Cancer Centre, Milan, Italy

Ospedale San Raffaele, Milan, Italy

Istituti Fisioterapici Ospitalieri, Roma, Italy

National Cancer Center Hospital, Chūōku, Japan

St. Marianna University School of Medicine Hospital, Kawasaki, Japan

Osaka International Cancer Institute, Osaka, Japan

National Cancer Center East, Tokyo, Japan

NKI, Amsterdam, Netherlands

Amsterdam Medical Center, Amsterdam, Netherlands

Radboud University Medical Center, Nijmegen, Netherlands

University Hospital Oslo, Oslo, Norway

National Cancer Centre of Singapore PTE LTD, Singapore, Singapore, Singapore

Samsung Medical Center, Seoul, South Korea

Seoul National University College of Medicine, Seoul, South Korea

Severance Hospital- Yonsei Cancer Center, Seoul, South Korea

Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain

START Hospital Fundación Jiménez Diaz, Madrid, Spain

START Hospital Universitario Madrid Sanchinarro, Madrid, Spain

Hospital 12 de Octubre, Madrid, Spain

Clínica Universidad de Navarra, Pamplona, Spain

Instituto Valenciano Oncologia, Valencia, Spain

Karolinska Universitetssjukhuset, Solna, Sweden

National Taiwan University Hospital 7, Taipei, Taiwan

Sarah Cannon Research Institute, London, United Kingdom